Innovaccer Expands into Public Sector to Facilitate More Equitable and Coordinated Care
Leading health cloud platform company assists public health case management, population health management and value-based analytics for Medicaid services SAN...
Day: July 13, 2022
Anumana Collaborates with Leading Global Health Care Company to Detect Heart Disease Using Artificial Intelligence
Novartis Pharmaceuticals Corporation to collaborate on development of new medical device software for earlier detection and intervention in cardiovascular disease...
Model N Announces Date of Third Quarter Fiscal Year 2022 Financial Results
SAN MATEO, Calif.--(BUSINESS WIRE)--Model N, Inc. (MODN), a leader in revenue optimization and compliance, plans to announce financial results for...
Synchron Appoints Kurt Haggstrom as Chief Commercial Officer
NEW YORK--(BUSINESS WIRE)--Synchron, an endovascular brain-computer (BCI) interface company, today announced the appointment of Kurt Haggstrom as Chief Commercial Officer....
Hologic Showcases Advances across the Continuum of Breast Health at ECR 2022
--Global Leader in Women's Health Highlights Importance of Timely and Accurate Diagnosis-- MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #3DMammography--Hologic, Inc. (Nasdaq: HOLX) will...
Resaphene Suisse AG: FDA Approval Process for Tinnitus Therapy Tinniwell Continues
ROGGWIL, Switzerland--(BUSINESS WIRE)--Due to the COVID pandemic, work for the FDA approval of the tinniwell was stopped at the beginning...
Tebra Names Kevin Marasco as Chief Marketing Officer
SaaS Veteran to Lead Marketing Efforts for All-in-One Solution for Independent Practices NEWPORT BEACH, Calif.--(BUSINESS WIRE)--#EHR--Tebra, the digital backbone for...
Glaukos to Release Second Quarter 2022 Financial Results after Market Close on August 3
Conference Call and Webcast Scheduled for 1:30 p.m. PT ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology...
XVIVO Presents Interim Report January-June 2022
GOTHENBURG, SWEDEN / ACCESSWIRE / July 13, 2022 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Strong sales growth and increased gross marginsSecond quarter...
Relief Signs a Definitive Agreement to Acquire a Novel Dosage Form of an Already Approved Prescription Drug for the Treatment of PKU
Company acquires an additional therapeutic product for the management of patients with PKU for worldwide markets, with the exception of...